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UN efforts to come up with a
resolution on the thorny issue of
human cloning were stalled again
last month as countries were
unable to reach agreement on the
issue of therapeutic cloning, the
extraction of cells from early
embryos which are subsequently
destroyed. Britain, Japan, South
Korea, India and many other
close US allies sought to head off
the previous Bush
administration’s campaign to
seek a global ban on all forms of
human cloning, saying it would
undercut scientific efforts to
develop cures for cancer,
diabetes and a host of other
diseases.
The former Bush administration
led diplomatic efforts to rally
international backing for a Costa
Rican resolution that would have
outlawed all forms of human
cloning, including the use of human
embryos in stem-cell research. The
initiative, which George Bush
promoted during his address to the
UN assembly on September 21,
goes beyond the restrictions
imposed on cloning by US law. It
would increase pressure on
governments to adopt a total ban.
The current dispute revives a
highly acrimonious debate on
human cloning at he United
Nations for the third consecutive
year. It mirrors the dispute on
human cloning that played out in
the US presidential campaign.
Bush and John Kerry staked out
sharply different positions, with
the Democratic candidate
advocating the use of embryos
from fertility clinics to pursue
medical research. Bush had
provided federal funding for
research on limited lines of human
embryonic stem cells for research.
But he also backed legislation that
would criminalize therapeutic
cloning.
The UN secretary general Kofi
Annan said that “In my personal
view, I think I will go for
therapeutic cloning.” But he said:
“Obviously, it's an issue for the
member states to decide.”
The governments of the US,
Costa Rica, and many other
European and Latin American
counties that support a total ban,
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argued that a partial ban would
encourage the creation of a black
market in human embryos.
In a brief statement, Susan
Moore, a US special adviser, told
the committee: “A ban that
differentiates between human
reproductive and experimental
cloning would essentially
authorise the creation of a human
embryo for the purpose of
destroying it, thus elevating the
value of research and
experimentation above that of a
human life.”
She said the US supported
efforts to find breakthrough
treatment and cures for disease
but that it felt scientific progress
was possible without posing a
“threat to human dignity”.
Robert Tovar, Costa Rica's
minister of foreign affairs and
worship, said that “cloning
reduces the human being to a
mere object of industrial
production and manipulation.” He
added: “Today we must decide
whether the international
community will adopt a utilitarian
ethic that justifies the deliberate
creation of human embryos with
the purpose of destroying them
for scientific experiments.”
Opponents contended that by
ignoring the fact that there is little
likelihood of a consensus in the
UN on therapeutic cloning
research and pushing for a vote,
the sponsors of the broader
measure were effectively
destroying the possibility of
action on a ban on reproductive
cloning on which all nations
could agree.
Key European governments,
including that of Britain,
supported a Belgian resolution
calling for a partial ban on cloning
that would permit scientific
research pursuing cures for
diseases. “If other countries
decide they want to ban
therapeutic cloning, then we
respect that totally. All we are
asking for is the same respect in
return,” said Emyr Jones Parry,
Britain's ambassador to the UN.
He said that Britain would not
sign or be bound by a final
convention that called for a total
ban. Parry said the other
resolution “seeks to impose a
single dogmatic and inflexible
viewpoint on the rest of the world
and overturn decisions which
have been legitimately taken by
other national governments.”
Islamic countries, whose
religion rejects the notion that life
begins at conception, want more
time to consider their position on
the issue. Speaking on behalf of
the 57-member Organization of
the Islamic Conference, Turkey's
representative, Gokeen Tugral,
said the Islamic states are
opposed to a vote on either
resolution. “A vote on either of the
draft resolutions by which one
side would impose its views on
the other would only create a
negative atmosphere,” she said.
The US, Belgium and other
countries have continued
negotiations aimed at a
compromise. South Korea
proposed delaying the vote this
year and convening an
international scientific conference
on cloning to increase delegates'
understanding of the issue.
The current divisions within the
General Assembly's legal
committee do not favour
beginning serious negotiations on
human cloning, said Shin Kak
Soo, South Korea's representative
in the UN debate.
But even in the US, efforts were
being made ahead of the
presidential election to garner
support for stem-cell research. In
California, Silicon Valley tycoons,
Nobel laureates and Hollywood
celebrities were backing a
measure to devote $3 billion to
human embryonic stem cell
experiments. Massachusetts-
based Advance Cell Technology,
Inc. has announced it would open
a laboratory in the state if the vote
was backed.
The firm, which was first to
clone a human embryo, said it
would build a facility in California
because of the state’s support for
the controversial research.
If the stem-cell plan, known as
Proposition 71, won support, the
California Institute for
Regenerative Medicine will be
launched to manage the initiative,
including the distribution of funds
to universities, medical schools
and research facilities.
The institution would give
priority funding to candidates
unlikely to receive limited federal
funds but would not support
research on human reproductive
cloning. Up to 10 per cent of
available funds could be used to
develop research facilities for
non-profit entities within the first
five years of implementation of the
measure. Whatever the fate of the
proposal, pressure is likely to
continue for more research.
Proposition 71 had the support
of actor Michael J. Fox, who has
Parkinson’s disease (which may
be helped by stem-cell therapies).
It would expand embryonic stem-
cell research in California beyond
the limited cell lines that can be
studied with federal funding under
the 2001 policy of President
George Bush.
Bush allowed individual states
to frame their own stem-cell
policies, contrasting with the
ongoing wrangles in Brussels over
forging a common European
position.
Actor Christopher Reeve, who
died last month, was also a high-
profile advocate of stem-cell
research. He campaigned for a
relaxation on the ban imposed on
federal funding for research based
on embryonic stem cells created
after 2001.
John Kerry, the then
Democratic presidential
candidate, exploited Bush’s
ambiguities over issues such as
stem-cell research. Kerry pledged
$100 million to a programme
based on stem cells that were
created in vitro, not implanted,
and would otherwise be
discarded.
Some 22 Nobel laureates and
many other scientists supported
Proposition 71 as a way to get
around the previous Bush
administration’s restrictions. They
complained that the political
climate brought the field to a
virtual standstill in the US.
Many hoped that that support
for Proposition 71 would breathe
new life into the field 
“Stem-cell therapies have the
potential to alleviate suffering for
millions of Americans,” said
Leonard Zon, president of the
International Society for Stem Cell
Research. It is clear this issue will
not disappear.
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